Selected research
Industry Research
Medical Radioactive Microsphere Injection Industry Research Report 2026
Market perspective
The global Medical Radioactive Microsphere Injection market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Medical Radioactive Microsphere Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Medical Radioactive Microsphere Injection is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Medical Radioactive Microsphere Injection is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Medical Radioactive Microsphere Injection include YH Nu-Med, Grand Pharmaceutical Group Limited, New Radiomedicine Technology, Boston Scientific, Terumo, Sirtex Medical Limited, BWXT Medical, AtomVie and ABK Biomedical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Medical Radioactive Microsphere Injection market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Medical Radioactive Microsphere Injection Market by Company
YH Nu-Med
Grand Pharmaceutical Group Limited
New Radiomedicine Technology
Boston Scientific
Terumo
Sirtex Medical Limited
BWXT Medical
AtomVie
ABK Biomedical
Medical Radioactive Microsphere Injection Segment by Type
Holmium 166 Microsphere Injection
Yttrium 90 Microsphere Injection
Others
Medical Radioactive Microsphere Injection Segment by Application
Cancer Treatment
Diagnosis
Others
Medical Radioactive Microsphere Injection Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Radioactive Microsphere Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Medical Radioactive Microsphere Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Radioactive Microsphere Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Medical Radioactive Microsphere Injection manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Medical Radioactive Microsphere Injection by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Medical Radioactive Microsphere Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Holmium 166 Microsphere Injection
- Yttrium 90 Microsphere Injection
- Others
Applications
- Cancer Treatment
- Diagnosis
- Others
Companies covered
- YH Nu-Med
- Grand Pharmaceutical Group Limited
- New Radiomedicine Technology
- Boston Scientific
- Terumo
- Sirtex Medical Limited
- BWXT Medical
- AtomVie
- ABK Biomedical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Medical Radioactive Microsphere Injection Market Size (2021-2032)
- 2.2.2 Global Medical Radioactive Microsphere Injection Sales (2021-2032)
- 2.2.3 Global Medical Radioactive Microsphere Injection Market Average Price (2021-2032)
- 2.3 Medical Radioactive Microsphere Injection by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Holmium 166 Microsphere Injection
- 2.3.3 Yttrium 90 Microsphere Injection
- 2.3.4 Others
- 2.4 Medical Radioactive Microsphere Injection by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Cancer Treatment
- 2.4.3 Diagnosis
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Medical Radioactive Microsphere Injection Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Medical Radioactive Microsphere Injection Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Medical Radioactive Microsphere Injection Revenue of Manufacturers (2021-2026)
- 3.4 Global Medical Radioactive Microsphere Injection Average Price by Manufacturers (2021-2026)
- 3.5 Global Medical Radioactive Microsphere Injection Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Medical Radioactive Microsphere Injection, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Medical Radioactive Microsphere Injection, Product Type & Application
- 3.8 Global Manufacturers of Medical Radioactive Microsphere Injection, Established Date
- 3.9 Global Medical Radioactive Microsphere Injection Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 YH Nu-Med
- 4.1.1 YH Nu-Med Company Information
- 4.1.2 YH Nu-Med Business Overview
- 4.1.3 YH Nu-Med Medical Radioactive Microsphere Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 YH Nu-Med Medical Radioactive Microsphere Injection Product Portfolio
- 4.1.5 YH Nu-Med Recent Developments
- 4.2 Grand Pharmaceutical Group Limited
- 4.2.1 Grand Pharmaceutical Group Limited Company Information
- 4.2.2 Grand Pharmaceutical Group Limited Business Overview
- 4.2.3 Grand Pharmaceutical Group Limited Medical Radioactive Microsphere Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Grand Pharmaceutical Group Limited Medical Radioactive Microsphere Injection Product Portfolio
- 4.2.5 Grand Pharmaceutical Group Limited Recent Developments
- 4.3 New Radiomedicine Technology
- 4.3.1 New Radiomedicine Technology Company Information
- 4.3.2 New Radiomedicine Technology Business Overview
- 4.3.3 New Radiomedicine Technology Medical Radioactive Microsphere Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 New Radiomedicine Technology Medical Radioactive Microsphere Injection Product Portfolio
- 4.3.5 New Radiomedicine Technology Recent Developments
- 4.4 Boston Scientific
- 4.4.1 Boston Scientific Company Information
- 4.4.2 Boston Scientific Business Overview
- 4.4.3 Boston Scientific Medical Radioactive Microsphere Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Boston Scientific Medical Radioactive Microsphere Injection Product Portfolio
- 4.4.5 Boston Scientific Recent Developments
- 4.5 Terumo
- 4.5.1 Terumo Company Information
- 4.5.2 Terumo Business Overview
- 4.5.3 Terumo Medical Radioactive Microsphere Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Terumo Medical Radioactive Microsphere Injection Product Portfolio
- 4.5.5 Terumo Recent Developments
- 4.6 Sirtex Medical Limited
- 4.6.1 Sirtex Medical Limited Company Information
- 4.6.2 Sirtex Medical Limited Business Overview
- 4.6.3 Sirtex Medical Limited Medical Radioactive Microsphere Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Sirtex Medical Limited Medical Radioactive Microsphere Injection Product Portfolio
- 4.6.5 Sirtex Medical Limited Recent Developments
- 4.7 BWXT Medical
- 4.7.1 BWXT Medical Company Information
- 4.7.2 BWXT Medical Business Overview
- 4.7.3 BWXT Medical Medical Radioactive Microsphere Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 BWXT Medical Medical Radioactive Microsphere Injection Product Portfolio
- 4.7.5 BWXT Medical Recent Developments
- 4.8 AtomVie
- 4.8.1 AtomVie Company Information
- 4.8.2 AtomVie Business Overview
- 4.8.3 AtomVie Medical Radioactive Microsphere Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 AtomVie Medical Radioactive Microsphere Injection Product Portfolio
- 4.8.5 AtomVie Recent Developments
- 4.9 ABK Biomedical
- 4.9.1 ABK Biomedical Company Information
- 4.9.2 ABK Biomedical Business Overview
- 4.9.3 ABK Biomedical Medical Radioactive Microsphere Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 ABK Biomedical Medical Radioactive Microsphere Injection Product Portfolio
- 4.9.5 ABK Biomedical Recent Developments
5 Global Medical Radioactive Microsphere Injection Market Scenario by Region
- 5.1 Global Medical Radioactive Microsphere Injection Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Medical Radioactive Microsphere Injection Sales by Region: 2021-2032
- 5.2.1 Global Medical Radioactive Microsphere Injection Sales by Region: 2021-2026
- 5.2.2 Global Medical Radioactive Microsphere Injection Sales by Region: 2027-2032
- 5.3 Global Medical Radioactive Microsphere Injection Revenue by Region: 2021-2032
- 5.3.1 Global Medical Radioactive Microsphere Injection Revenue by Region: 2021-2026
- 5.3.2 Global Medical Radioactive Microsphere Injection Revenue by Region: 2027-2032
- 5.4 North America Medical Radioactive Microsphere Injection Market Facts & Figures by Country
- 5.4.1 North America Medical Radioactive Microsphere Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Medical Radioactive Microsphere Injection Sales by Country (2021-2032)
- 5.4.3 North America Medical Radioactive Microsphere Injection Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Medical Radioactive Microsphere Injection Market Facts & Figures by Country
- 5.5.1 Europe Medical Radioactive Microsphere Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Medical Radioactive Microsphere Injection Sales by Country (2021-2032)
- 5.5.3 Europe Medical Radioactive Microsphere Injection Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Medical Radioactive Microsphere Injection Market Facts & Figures by Country
- 5.6.1 Asia Pacific Medical Radioactive Microsphere Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Medical Radioactive Microsphere Injection Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Medical Radioactive Microsphere Injection Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Medical Radioactive Microsphere Injection Market Facts & Figures by Country
- 5.7.1 South America Medical Radioactive Microsphere Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Medical Radioactive Microsphere Injection Sales by Country (2021-2032)
- 5.7.3 South America Medical Radioactive Microsphere Injection Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Medical Radioactive Microsphere Injection Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Medical Radioactive Microsphere Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Medical Radioactive Microsphere Injection Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Medical Radioactive Microsphere Injection Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Medical Radioactive Microsphere Injection Sales by Type (2021-2032)
- 6.1.1 Global Medical Radioactive Microsphere Injection Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Medical Radioactive Microsphere Injection Sales Market Share by Type (2021-2032)
- 6.2 Global Medical Radioactive Microsphere Injection Revenue by Type (2021-2032)
- 6.2.1 Global Medical Radioactive Microsphere Injection Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Medical Radioactive Microsphere Injection Revenue Market Share by Type (2021-2032)
- 6.3 Global Medical Radioactive Microsphere Injection Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Medical Radioactive Microsphere Injection Sales by Application (2021-2032)
- 7.1.1 Global Medical Radioactive Microsphere Injection Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Medical Radioactive Microsphere Injection Sales Market Share by Application (2021-2032)
- 7.2 Global Medical Radioactive Microsphere Injection Revenue by Application (2021-2032)
- 7.2.1 Global Medical Radioactive Microsphere Injection Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Medical Radioactive Microsphere Injection Revenue Market Share by Application (2021-2032)
- 7.3 Global Medical Radioactive Microsphere Injection Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Medical Radioactive Microsphere Injection Value Chain Analysis
- 8.1.1 Medical Radioactive Microsphere Injection Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Medical Radioactive Microsphere Injection Production Mode & Process
- 8.2 Medical Radioactive Microsphere Injection Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Medical Radioactive Microsphere Injection Distributors
- 8.2.3 Medical Radioactive Microsphere Injection Customers
9 Global Medical Radioactive Microsphere Injection Analyzing Market Dynamics
- 9.1 Medical Radioactive Microsphere Injection Industry Trends
- 9.2 Medical Radioactive Microsphere Injection Industry Drivers
- 9.3 Medical Radioactive Microsphere Injection Industry Opportunities and Challenges
- 9.4 Medical Radioactive Microsphere Injection Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst